Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chabbert Y. A., Lutz A. J. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity. Antimicrob Agents Chemother. 1978 Nov;14(5):749–754. doi: 10.1128/aac.14.5.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cone L. A., Woodard D., Helm N. A. Clinical experience in the diagnosis and treatment of infections in the compromised host. Clin Ther. 1981;4 (Suppl A):45–54. [PubMed] [Google Scholar]
- Gineston J. L., Henry X. Recto-colite pseudomambraneuse après traitement par le céfotaxime. Nouv Presse Med. 1982 May 29;11(25):1951–1952. [PubMed] [Google Scholar]
- Karakusis P. H., Feczko J. M., Goodman L. J., Hanlon D. M., Harris A. A., Levin S., Trenholme G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob Agents Chemother. 1982 Jan;21(1):119–124. doi: 10.1128/aac.21.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Larson H. E., Parry J. V., Price A. B., Davies D. R., Dolby J., Tyrrell D. A. Undescribed toxin in pseudomembranous colitis. Br Med J. 1977 May 14;1(6071):1246–1248. doi: 10.1136/bmj.1.6071.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Larson H. E., Price A. B. Pseudomembranous colitis: Presence of clostridial toxin. Lancet. 1977 Dec 24;2(8052-8053):1312–1314. doi: 10.1016/s0140-6736(77)90363-4. [DOI] [PubMed] [Google Scholar]
- Mader J. T., LeFrock J. L., Hyams K. C., Molavi A., Reinarz J. A. Cefotaxime therapy for patients with osteomyelitis and septic arthritis. Rev Infect Dis. 1982 Sep-Oct;4 (Suppl):S472–S480. doi: 10.1093/clinids/4.supplement_2.s472. [DOI] [PubMed] [Google Scholar]